The Food and Drug Administration announced it has granted Moderna’s COVID-19 vaccine full approval for use in adults on Monday.
The mRNA-based vaccine, also known as Spikevax, has been in use in the US for over 11 months under an emergency use authorization.
“The public can be assured that Spikevax meets the FDA’s high standards for safety, effectiveness and manufacturing quality required of any vaccine approved for use in the United States,” Acting FDA Commissioner Janet Woodcock said in a statement.
Load More
Yorumlar
Kalan Karakter: